Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's diseaseMiranda E. Orr, Nicolas Musi|Research Square|2023Cited by 37
Symposia Report of The Annual Biological Sciences Section Meeting of the Gerontological Society of America 2023, Tampa, FloridaBlanka Rogina, Vera Gorbunova, Matthew J. Yousefzadeh et al.|The Journals of Gerontology Series A|2025Cited by 0